Generalized anxiety disorder

Last updated: January 09, 2026

Generalized anxiety disorder

C7

C7

Mood disorders: Clinical
Anxiety disorders: Clinical
Schizophrenia spectrum disorders: Clinical
Dissociative disorders: Clinical
Eating disorders: Clinical
Obsessive compulsive disorders: Clinical
Trauma- and stressor-related disorders: Clinical
Disruptive, impulse-control and conduct disorders: Clinical
Personality disorders: Clinical
Sleep disorders: Clinical
Somatic symptom disorders: Clinical
Sexual dysfunctions: Clinical
Paraphilic disorders: Clinical
Dementia and delirium: Clinical
Substance misuse and addiction: Clinical
Drug misuse, intoxication and withdrawal: Hallucinogens: Pathology review
Psychiatric emergencies: Pathology review
Schizophrenia spectrum disorders: Pathology review
Drug misuse, intoxication and withdrawal: Stimulants: Pathology review
Drug misuse, intoxication and withdrawal: Alcohol: Pathology review
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Monoamine oxidase inhibitors
Atypical antidepressants
Typical antipsychotics
Atypical antipsychotics
Lithium
Nonbenzodiazepine anticonvulsants
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Psychomotor stimulants
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid antagonists
Toxidromes: Clinical
Medication overdoses and toxicities: Pathology review
Environmental and chemical toxicities: Pathology review
Eating disorders: Pathology review
Major depressive disorder
Suicide
Bipolar and related disorders
Major depressive disorder with seasonal pattern
Premenstrual dysphoric disorder
Generalized anxiety disorder
Social anxiety disorder
Panic disorder
Agoraphobia
Phobias
Obsessive-compulsive disorder
Body focused repetitive disorders
Body dysmorphic disorder
Post-traumatic stress disorder
Physical and sexual abuse
Schizoaffective disorder
Schizophreniform disorder
Delusional disorder
Schizophrenia
Delirium
Amnesia
Dissociative disorders
Anorexia nervosa
Bulimia nervosa
Cluster A personality disorders
Cluster B personality disorders
Cluster C personality disorders
Somatic symptom disorder
Factitious disorder
Tobacco use disorder
Opioid use disorder
Cannabis use disorder
Cocaine use disorder
Alcohol use disorder
Serotonin syndrome
Neuroleptic malignant syndrome
Mood disorders: Pathology review
Amnesia, dissociative disorders and delirium: Pathology review
Personality disorders: Pathology review
Psychological sleep disorders: Pathology review
Malingering, factitious disorders and somatoform disorders: Pathology review
Trauma- and stress-related disorders: Pathology review
Developmental and learning disorders: Pathology review
Childhood and early-onset psychological disorders: Pathology review
Drug misuse, intoxication and withdrawal: Other depressants: Pathology review

Transcript

Watch video only

Generalized anxiety disorder, or GAD for short, is a mental health condition characterized by prolonged and excessive anxiety about everyday situations, such as finances, relationships, or day-to-day tasks. This anxiety is often out of proportion to the actual situation and can cause significant distress in daily functioning.

Imagine you have a big presentation coming up at school. You’ve been preparing for days, your slides look amazing, and you’ve practiced your delivery more times than you can count. But when you finally stand in front of the class to speak, your brain’s fear circuit suddenly kicks in.

The amygdala, which is an almond-shaped structure buried deep in the temporal lobe,

recognizes this situation as a potential threat and sends excitatory signals to the hypothalamus. The hypothalamus then activates the sympathetic nervous system, setting off a chain of reactions in the body, including a fast heartbeat, rapid breathing, sweating, muscle tension, and a dry mouth.

Meanwhile, the locus coeruleus in the brainstem releases norepinephrine, which floods the amygdala, activating beta-adrenergic receptors and pushing it into a state of hyperarousal. Additionally, adrenal glands start pumping out corticosteroids, which are stress hormones that can increase activity in fear-related circuits, making you more sensitive to stressful situations.

All these changes represent a typical anxiety response. It is uncomfortable but temporary and appropriate to the situation.

Once it’s all over and the room fills with applause, that wave of anxiety finally starts to fade. Your brain begins to wind down, and this is when the ventromedial prefrontal cortex comes into play. This part of the cortex directly inhibits the amygdala using the inhibitory neurotransmitter called GABA, quieting its activity and calming the anxiety response. At the same time, the ventromedial prefrontal cortex stimulates the raphe nuclei to release serotonin, which helps indirectly calm the amygdala even further.

Another key player in the fear circuit is the hippocampus. It helps your brain figure out whether a situation is actually dangerous or just feels that way because of something you've experienced before.

Now, in generalized anxiety disorder, the usual brake system between the ventromedial prefrontal cortex and the amygdala isn’t working properly. There’s not enough GABA and serotonin to keep the amygdala calm, while the locus coeruleus is working overtime and flooding the amygdala with norepinephrine. This pushes the amygdala into a constant state of high alert, keeping a person stuck in a state of excessive and disproportionate anxiety, fear, or worry. On top of that, when stress sticks around for too long, the body keeps pumping out corticosteroids, which can, over time, cause atrophy of the hippocampus and further impair the ability to manage stress.

Sources

    1. Kellerman, Rick D. Conn's Current Therapy 2025. Available from: ClinicalKey Student, Elsevier Limited (UK), 2024. (pg-766-768) 

    1. Davidson's Principles and Practice of Medicine. Available from: ClinicalKey Student, (24th Edition). Elsevier Limited (UK), 2022. (pg-1254-1255) 

    1. O'Connell, Theodore, X. et al. Crush Step 1 E-Book. Available from: ClinicalKey Student, (3rd Edition). Elsevier Limited (UK), 2023 (pg: 551-552) 

    1. Ferri, Fred F. Ferri's Clinical Advisor 2025. Available from: ClinicalKey Student, Elsevier Limited (UK), 2024. (pg-94-95) 

    1. Porta-Casteràs, D et al. “Prefrontal-amygdala connectivity in trait anxiety and generalized anxiety disorder: Testing the boundaries between healthy and pathological worries.” Journal of affective disorders vol. 267 (2020): 211-219. doi:10.1016/j.jad.2020.02.029